• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

    Reed-Lane Facility Virtual Tour
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Almac Group

    PCI Pharma Services

    Baxter BioPharma Solutions

    Reed-Lane

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Almac Group

    Alcami

    Aphena Pharma Solutions

    Syngene
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Rain Therapeutics Appoints Chief Science Officer

    Co-founder Robert Doebele transitions to Rain full-time.

    Related CONTENT
    • Celonic to Boost Cell & Gene Therapy Production
    • Aptamer Extends Collaboration with AstraZeneca
    • Amgen to Acquire Five Prime Therapeutics for $1.9B
    • Spark Therapeutics Appoints CTO
    • High Purity New England Bolsters Biopharma Solutions Services
    Contract Pharma Staff09.15.20

    Rain Therapeutics Inc.
    , a privately-held, clinical stage biotechnology company, has appointed Rain co-founder Robert Doebele, MD, PhD, as chief scientific officer (CSO).
     
    Doebele has served as chair of the scientific advisory board and acting CSO since Rain’s founding. He will now transition to Rain full-time in the executive vice president (EVP) and CSO role, departing his position at the University of Colorado, Denver as associate professor of medicine. In his new role, Doebele will be responsible for leading Rain’s research and development efforts.
     
    “Working with Bob since the founding of Rain has been a great privilege, and we are thrilled to officially welcome him in a full-time capacity,” said Avanish Vellanki, co-founder and chief executive officer of Rain. “As a visionary leader in the precision oncology space with unparalleled experience in developing tumor-agnostic approaches to cancer treatment, we are in keen anticipation of Bob’s impact on the corporate biotechnology industry post his departure from academia.”
     
    Doebele added, “Rain is at a pivotal juncture in its evolution, and I am excited to transition full time to the company. Rain’s pipeline, which now includes RAIN-32, a potent MDM2 inhibitor, and a RAD52 inhibitor program in addition to our first clinical candidate, Tarlox, has the potential to make a transformative impact in the lives of patients with difficult-to-treat cancers. I look forward to leading the team as we develop tumor-agnostic, biomarker-driven trials to advance our targeted oncology candidates.”
     
    Experience
     
    Doebele co-founded Rain Therapeutics in April 2017 and currently serves as chair of the scientific advisory board. Prior to joining Rain full time, Dr. Doebele served as associate professor of medicine in the division of medical oncology at the University of Colorado School of Medicine, director of the Thoracic Oncology Research Initiative at the University of Colorado Cancer Center and as principle investigator for the University of Colorado Lung Cancer Specialized Program of Research Excellence.
     
    In addition, he served as a senior editor of the AACR journal, Clinical Cancer Research and was elected to the American Society for Clinical Investigation in 2018. Doebele received his AB in molecular biology from Princeton University and received his MD and PhD in immunology from the University of Pennsylvania. He conducted his internal medicine residency and medical oncology fellowship at the University of Chicago.
    Related Searches
    • Clinical Trials
    Suggested For You
    Celonic to Boost Cell & Gene Therapy Production Celonic to Boost Cell & Gene Therapy Production
    Aptamer Extends Collaboration with AstraZeneca Aptamer Extends Collaboration with AstraZeneca
    Amgen to Acquire Five Prime Therapeutics for $1.9B Amgen to Acquire Five Prime Therapeutics for $1.9B
    Spark Therapeutics Appoints CTO Spark Therapeutics Appoints CTO
    High Purity New England Bolsters Biopharma Solutions Services High Purity New England Bolsters Biopharma Solutions Services
    CatSci Opens New Site in UK CatSci Opens New Site in UK
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement  Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Aevitas Therapeutics Appoints President and CEO Aevitas Therapeutics Appoints President and CEO
    Eurofins Scientific Acquires Beacon Discovery Eurofins Scientific Acquires Beacon Discovery
    Century Therapeutics Significantly Expands Capabilities Century Therapeutics Significantly Expands Capabilities
    Biomunex, Onward Ink Strategic Antibody Development Pact   Biomunex, Onward Ink Strategic Antibody Development Pact
    Molecular Templates, BMS Enter Strategic Research Pact Molecular Templates, BMS Enter Strategic Research Pact
    AbbVie, Caribou Ink CAR-T Collaboration AbbVie, Caribou Ink CAR-T Collaboration
    Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
    Catalent, Trizell Enter Cell Therapy Deal Catalent, Trizell Enter Cell Therapy Deal

    Related Breaking News

    • Breaking News | Clinical Trials
      Strata Oncology Unveils Strata PATH Trial

      Strata Oncology Unveils Strata PATH Trial

      The new platform clinical trial will evaluate FDA-approved therapies in novel biomarker profiles learned from real-world data.
      Charles Sternberg, Assistant Editor 03.02.21

    • Breaking News | Clinical Trials | CRO News | Information Technology
      Alimentiv Acquires McDougall Scientific

      Alimentiv Acquires McDougall Scientific

      Niche CRO specializes in statistical analysis, data management, reporting, and clinical trial design.
      Kristin Brooks 03.02.21

    • Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology
      Ashfield Engage, Popit Form Digital Monitoring Collaboration

      Ashfield Engage, Popit Form Digital Monitoring Collaboration

      Partner to improve patient adherence through supplemental real-time personalized support.
      Tim Wright, Editor, Contract Pharma 02.26.21


    • Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      RedHill and Cosmo Strengthen Manufacturing Agreements

      RedHill and Cosmo Strengthen Manufacturing Agreements

      Secures manufacturing capacity of Movantik for opioid-induced constipation and RHB-204, currently in a Phase 3 study for pulmonary NTM disease.
      Tim Wright, Editor, Contract Pharma 02.19.21

    • Breaking News | Clinical Trials | CRO News
      PPD Awarded US Army RPA Develop PTSD Drugs

      PPD Awarded US Army RPA Develop PTSD Drugs

      Adaptive platform clinical research trial design aims to expedite potential new treatments for veterans.
      Kristin Brooks 02.18.21

    • Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

      Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

      For EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody.
      Tim Wright, Editor, Contract Pharma 02.12.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      Catalent, Decibel Team Up for Hearing Loss Treatment

      Catalent, Decibel Team Up for Hearing Loss Treatment

      Enter development and manufacturing agreement for dual-vector gene therapy for the treatment of congenital hearing loss.
      Tim Wright, Editor, Contract Pharma 02.04.21

    • Breaking News | Clinical Trials | Drug Development | Industry News
      Affimed, Roche Explore AFM24, Tecentriq Combo

      Affimed, Roche Explore AFM24, Tecentriq Combo

      To investigate the combination for the treatment of advanced solid epidermal growth factor receptor (EGFR) expressing malignancies.
      Kristin Brooks 02.03.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
      Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement

      Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement

      Abzena will work with Immunome to produce the antibody cocktail for clinical testing.
      Kristin Brooks 02.03.21


    • Bio News | Breaking News | cGMP Manufacture | Clinical Trials | Collaborations & Alliances | Industry News
      RedHill and Cosmo Expand Opaganib Manufacturing Deal

      RedHill and Cosmo Expand Opaganib Manufacturing Deal

      New agreement expands manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study.
      Tim Wright, Editor, Contract Pharma 02.02.21

    • Breaking News | Clinical Trials | Drug Development | Industry News
      DoD Awards Rigel $16.5M to Support Fostamatinib COVID Trials

      DoD Awards Rigel $16.5M to Support Fostamatinib COVID Trials

      Will evaluate the safety and efficacy of fostamatinib in hospitalized COVID-19 patients without respiratory failure.
      Kristin Brooks 02.01.21

    • Breaking News | Clinical Trials | Industry News
      Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

      Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

      Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.
      Kristin Brooks 01.26.21


    • Breaking News | Clinical Trials | Drug Development | Industry News | Laboratory Testing
      Caprion-HistoGeneX Rebrands as CellCarta

      Caprion-HistoGeneX Rebrands as CellCarta

      Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.
      Kristin Brooks 01.26.21

    • Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      Humanigen, Emergent Enter Covid-19 Partnership

      Humanigen, Emergent Enter Covid-19 Partnership

      Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.
      Tim Wright, Editor, Contract Pharma 01.25.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
      Intravacc Completes Project for Provention Bio’s Vax Candidate

      Intravacc Completes Project for Provention Bio’s Vax Candidate

      Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.
      Contract Pharma Staff 01.19.21

    Trending
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Reed-Lane Facility Virtual Tour
    Breaking News
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    • Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    • Aptamer Extends Collaboration with AstraZeneca
    • Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President and COO
    Ashland Completes Expansion and Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login